Slovenia's industrial output fell by 1.2 percent in 2024, marking the second consecutive year of decline, the country's Statistical Office reported on Monday.

Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

Trek through alpine peaks, underground caves, and historic battlefields in this under-the-radar adventure hot spot.

Morphosis Capital Partners BV announced the official launch of Morphosis Capital Fund II, its second investment fund, with a ...